Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 23, 2022
Patent Application Number
16849728
Date Filed
April 15, 2020
Patent Citations Received
Patent Primary Examiner
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating deseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
